FishRook
(The Hill) — Long awaited COVID-19 shots for the youngest children are one step closer to being available after a Food and Drug Administration advisory panel on Wednesday recommended the agency grant emergency authorization to vaccines from Pfizer and Moderna.
An outside Food and Drug Administration advisory panel on Wednesday unanimously recommended the vaccines should be authorized; Moderna’s for children between the ages of 6 months and 5 years, and Pfizer’s for kids 6 months to 4 years old.
The FDA’s vaccine advisors voted 21 to zero to recommend authorizing Moderna’s vaccine, and then again 21 to zero in favor of Pfizer.
An advisory panel for the Centers for Disease Control and Prevention will meet this weekend to issue its own recommendation. If the panel votes in the affirmative and the CDC director signs off, children could start to get vaccinated as early as next week.
More than a year and a half…
